Ventricular arrhythmias, conclusion: new agents, additional treatment modalities, and overall approach to the problem.
In this final installment, we discuss use of the newer antiarrhythmic agents and indications for additional treatment modalities such as programmed electrophysiologic stimulation (PES), surgery, and implantation of the automatic cardioverter-defibrillator. We conclude with our approach for evaluating the efficacy of antiarrhythmic therapy.
Grauer
K
K
University of Florida, College of Medicine, Gainesville.
Gums
J
J
D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000601:surgery; D006352:Heart Ventricles; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods
D000889:Anti-Arrhythmia Agents